A PHASE IIB, MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF CK-2017357 IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS)
Principal Investigator(s)
Jackson,Carlayne E
Funded by
CYTOKINETICS
Research Start Date
Status
Inactive